Table 1. Characteristics of patients and their breast cancers.
Characteristics | No. of patients | % |
Age | ||
<40 | 16 | 8.6 |
40–50 | 64 | 39.8 |
51–70 | 96 | 46.2 |
>70 | 10 | 5.4 |
Histology | ||
ILC | 28 | 15.1 |
IDC | 127 | 68.3 |
Medullary | 16 | 8.6 |
DCIS/LCIS | 15 | 8.1 |
AJCC Stage | ||
0 | 14 | 7.5 |
1 | 14 | 7.5 |
2 | 99 | 53.3 |
3 | 59 | 31.7 |
Axillary node | ||
0 | 82 | 44.6 |
1–3 | 44 | 23.1 |
>3 | 60 | 32.3 |
Tumor size (cm) | ||
0–0.9 | 2 | 1.1 |
1–1.9 | 21 | 10.8 |
2–2.9 | 45 | 23 |
>3 | 118 | 65.1 |
SBR Score | ||
1 | 21 | 11.4 |
2 | 60 | 33.3 |
3 | 90 | 47.3 |
Estrogen receptor | ||
Positive | 94 | 50.5 |
Negative | 92 | 49.5 |
Progesterone receptor | ||
Positive | 82 | 44.1 |
Negative | 104 | 55.9 |
CerbB-2 | ||
Positive | 58 | 31.2 |
Negative | 128 | 68.8 |
PCNA | ||
High(>47) | 111 | 59.7 |
Low(≤47) | 75 | 40.3 |
p53 | ||
Positive | 69 | 37.1 |
Negative | 117 | 62.9 |
Nm23 | ||
High | 81 | 43.5 |
Low | 105 | 56.5 |
Abbreviations: ILC, Infiltrating lobular carcinoma; IDC, infiltrating ductal carcinoma;
MC, medullary carcinoma; CIS, carcinoma in situ; DCIS/LCIS, ductal carcinoma in situ/
Lobular carcinoma in situ; AJCC, American Joint Committee on Cancer;
SBR, Scarff-Bloom-Richardson.